MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 26 filers reported holding MERUS N V in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14 | -100.0% | 541 | -98.8% | 0.00% | -100.0% |
| Q1 2022 | $1,152,000 | -27.2% | 43,716 | -12.3% | 0.01% | -16.7% |
| Q4 2021 | $1,583,000 | -23.3% | 49,871 | -47.0% | 0.01% | -25.0% |
| Q3 2021 | $2,065,000 | +95.4% | 94,134 | +87.7% | 0.01% | +100.0% |
| Q2 2021 | $1,057,000 | +4495.7% | 50,142 | +2555.8% | 0.00% | – |
| Q3 2020 | $23,000 | +15.0% | 1,888 | +17.0% | 0.00% | – |
| Q1 2020 | $20,000 | -88.2% | 1,613 | -86.6% | 0.00% | -100.0% |
| Q4 2019 | $170,000 | +3.0% | 12,035 | +29.5% | 0.00% | 0.0% |
| Q3 2019 | $165,000 | +5.8% | 9,295 | -12.8% | 0.00% | 0.0% |
| Q2 2019 | $156,000 | -0.6% | 10,655 | -0.3% | 0.00% | 0.0% |
| Q1 2019 | $157,000 | -58.8% | 10,688 | -60.7% | 0.00% | -50.0% |
| Q4 2018 | $381,000 | -29.1% | 27,215 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $537,000 | – | 27,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |